Strategic appointment announced by Recipharm

Contract development and manufacturing organisation (CDMO), Recipharm, has announced the strategic appointment in the UK and Ireland of Shabbir Mostafa. Mostafa will join the business management team as director.

“The UK and Ireland continues to be an important market for Recipharm as we expand our localised presence throughout Europe,” explained Kenth Berg, vice president business management at Recipharm. “As we continue to grow as a company, with our focus on decentralised operations, we are highly dependent on talented people at key posts throughout the Recipharm organisation. With his extensive knowledge of the pharmaceutical sector in the UK and Ireland, we believe Shabbir is the perfect addition to our team and will help to drive our business forward in this key market.”

Mostafa joins Recipharm from Aesica Pharmaceuticals where he was the business development director with responsibility for global formulation development services and the commercial finished dose business within the UK and Ireland.

“Recipharm is highly regarded as a significant force in the pharmaceutical sector and as the CDMO continues to expand its presence and service offering globally, it’s an exciting time to join the team,” said Mostafa. “Recipharm is focused on simplifying the supply chain and managing complexity on behalf of pharmaceutical companies across the world and I look forward to playing my part by supporting our customers in the UK and Ireland.”